speb/financial-data huggingface dataset:
ACU.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -30658.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 809011.00
ACU.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -15938.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1774339.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 68201.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 68201.00
ACU.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -185239.00
ACU.V income_statement (quarterly, 2025-09-30) — Normalized Income: -339878.55
ACU.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 1004746.00
ACU.V income_statement (quarterly, 2025-09-30) — Operating Income: -479576.00
ACU.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 991581.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 7722.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 780973.00
ACU.V income_statement (quarterly, 2025-09-30) — Other Gand A: 198604.00
ACU.V income_statement (quarterly, 2025-09-30) — Other Income Expense: 207986.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 333147.00
ACU.V cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 985.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 44174.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 5.00
ACU.V income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 198423.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 555494.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 1807790.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 167175.00
ACU.V income_statement (quarterly, 2025-09-30) — Pretax Income: -302247.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
ACU.V cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -4636.00
ACU.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -15938.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Raw Materials: 2538941.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Receivables: 495034.00
ACU.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 343893.00
ACU.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 95913.00
ACU.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -739336.00
ACU.V income_statement (quarterly, 2025-09-30) — Research And Development: 143908.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 45775.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -29868696.00
ACU.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 621953.00
ACU.V income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 66886.00
ACU.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 887443.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 222194076.00
ACU.V income_statement (quarterly, 2025-09-30) — Special Income Charges: 1593.00
ACU.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 23758.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 2107486.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1774339.00
ACU.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 1434.45
ACU.V income_statement (quarterly, 2025-09-30) — Tax Provision: 29503.00
ACU.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.15
ACU.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 220986.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 6235660.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2140262.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 530672.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 2107486.00
ACU.V income_statement (quarterly, 2025-09-30) — Total Expenses: 1471157.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4128174.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 1186332.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 366840.00
ACU.V income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -470012.00
ACU.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: 9563.00
ACU.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 9563.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Work In Process: 1083029.00
ACU.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 1287994.00
ACU.V income_statement (quarterly, 2025-09-30) — Write Off: -1593.00
ACU.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 1263524.00
ACU.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 428683.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 481990.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -948052.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 3507117.00
ACU.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: -1472.00
ACU.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
ACU.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 613189.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 993998.00
ACU.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -79900.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 402134.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 322183.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 322183.00
ACU.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 322183.00
ACU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 21204.00
ACU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -81025.00
ACU.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -279425.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: 99273.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 237257.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 469392.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -8415.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: -82446.00
ACU.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 715061.00
ACU.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -82446.00
ACU.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -339246.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 933972.00
ACU.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 279872.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 4751447.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 259195.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Debt: 121333.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 380528.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1902598.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1902598.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 4655007.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Current Provisions: 35765.00
ACU.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 0.00
ACU.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: 0.00
ACU.V cash_flow (quarterly, 2025-12-31) — Depreciation: 167856.00
ACU.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 167856.00
ACU.V income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 167856.00
ACU.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 167856.00
ACU.V income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 167856.00
ACU.V income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 167856.00
ACU.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.01
ACU.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — EBIT: -950021.00
ACU.V income_statement (quarterly, 2025-12-31) — EBITDA: -782165.00
ACU.V cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 48240.00
ACU.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 322183.00
ACU.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 21204.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Finished Goods: 192150.00
ACU.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -359325.00
ACU.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: -406.00
ACU.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -68389.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 775102.00
ACU.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 808038.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 332813.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1669758.00
ACU.V income_statement (quarterly, 2025-12-31) — Gross Profit: 148811.00
ACU.V income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
ACU.V income_statement (quarterly, 2025-12-31) — Interest Expense: 7225.00
ACU.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 7225.00
ACU.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -10757.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Inventory: 3628882.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 1074046.00
ACU.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -81025.00
ACU.V cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 113446.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Leases: 18150.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 121333.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 142939.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 18741.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 161680.00
ACU.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -81485.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 32405.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 99183.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1186279.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -1186279.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -1186279.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -22043.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -7225.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 31961.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -81485.00
ACU.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -7225.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1125.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 721706.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -57857.00
ACU.V cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 113446.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 601159.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 68201.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 68201.00
ACU.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -715248.00
ACU.V income_statement (quarterly, 2025-12-31) — Normalized Income: -1129399.55
ACU.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -279425.00
ACU.V cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -406.00
ACU.V income_statement (quarterly, 2025-12-31) — Operating Income: -1114713.00
ACU.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 428683.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 775102.00
ACU.V income_statement (quarterly, 2025-12-31) — Other Gand A: 197973.00
ACU.V income_statement (quarterly, 2025-12-31) — Other Income Expense: 164691.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 332813.00
ACU.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 7179.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 45299.00
ACU.V income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 231608.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Other Properties: 558427.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 2336116.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 175590.00
ACU.V income_statement (quarterly, 2025-12-31) — Pretax Income: -957246.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ACU.V cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -22043.00
ACU.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -57857.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2670594.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Receivables: 578952.00
ACU.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 279872.00
ACU.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 167856.00
ACU.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -81485.00
ACU.V income_statement (quarterly, 2025-12-31) — Research And Development: 178454.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 45840.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -31054975.00
ACU.V income_statement (quarterly, 2025-12-31) — Salaries And Wages: 610065.00
ACU.V income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 109176.00
ACU.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 917214.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 222194076.00
ACU.V cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 113446.00
ACU.V income_statement (quarterly, 2025-12-31) — Special Income Charges: 1472.00
ACU.V cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 18636.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 933972.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 601159.00
ACU.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -10037.55
ACU.V income_statement (quarterly, 2025-12-31) — Tax Provision: 229033.00
ACU.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.15
ACU.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 96962.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 5851265.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 952713.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 542208.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 933972.00
ACU.V income_statement (quarterly, 2025-12-31) — Total Expenses: 1543396.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 4917293.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1099818.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 262286.00
ACU.V income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1181629.00
ACU.V income_statement (quarterly, 2025-12-31) — Total Unusual Items: -66917.00
ACU.V income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -66917.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Work In Process: 766138.00
ACU.V balance_sheet (quarterly, 2025-12-31) — Working Capital: 96440.00
ACU.V income_statement (quarterly, 2025-12-31) — Write Off: -1472.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — +Operating Expense: 1522033000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — +Total Revenue: 5201350000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 1184176000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1637022000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -265801000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2765661000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -173000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 37731000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 68422349.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Basic EPS: 10.52
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 26846000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 545341000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -337581000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 364371000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 102966000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 615461000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 102966000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -518078000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -247061000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: -105333000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Payable: 326788000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -417745000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -942145000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 76121000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Common Stock: 364371000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 5222739000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Common Stock Issuance: 2999999000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 29605000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 2728363000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Assets: 4291468000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Debt: 2560000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 2560000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 0.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 1293206000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 60206000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Depreciation: 100802000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 100802000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 100802000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 100802000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 68422349.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Diluted EPS: 10.52
ACUTAAS.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 719461000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — EBIT: 978577000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — EBITDA: 1079379000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — End Cash Position: 102966000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: 1402625000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 304902000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: -456928000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -5924000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 43752000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Goodwill: 185956000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 267261000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 1637195000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 2073483000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Gross Profit: 2472987000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Interest Expense: 64073000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 64073000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Interest Income: 25819000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 25819000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -54491000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 25818000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Inventory: 1121709000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 5231180000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -1207157000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 37731000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 2999999000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 199258000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 5881000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 5881000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 4360000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1299279000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 2999999000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Foreign Currency Exchange Gain Loss: 12879000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income: 719461000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 719461000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 719461000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 719461000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 719461000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 914504000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 719461000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Interest Income: -64073000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: -2845000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -1357916000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -1357916000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -64073000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -892549000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Net PPE: 1807682000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -337581000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 4955478000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 62643000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 4360000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 77915000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 1079379000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Normalized Income: 719461000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: -119347000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Operating Income: 950954000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Operating Revenue: 5201350000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 72874124.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 481277000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 46264000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 4858368000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 81305000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Investments: 10058000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 28674000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 66613000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 27623000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 1007567000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Payable: 44928000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Properties: 1778088000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 111087000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 512495000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Payables: 1229104000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: 8065000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 376729000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Pretax Income: 914504000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -2845000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -337581000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 816807000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 2728363000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 100802000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 3681000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 3681000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Research And Development: 1233000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 380054000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 2032272000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 202559000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 246311000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Share Issued: 72874124.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Special Income Charges: 0.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 5222739000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 4955478000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Tax Provision: 195043000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.21
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 49406000.00
ACUTAAS.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: -228138000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Assets: 6588829000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 5228620000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Debt: 8441000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 5222739000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Total Expenses: 4250396000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 1366090000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 2297361000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 72884000.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 4309000.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Total Unusual Items: 0.00
ACUTAAS.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: 0.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Work In Process: 0.00
ACUTAAS.NS balance_sheet (annual, 2022-03-31) — Working Capital: 2998262000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1283677000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — +Total Revenue: 6130573000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 1420477000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 2302611000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -386940000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2727684000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -398000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 213000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 33392000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 72874124.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Basic EPS: 11.43
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 102966000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 597601000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -964029000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 364371000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 305326000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 586702000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -109357000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 305326000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -70021000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 49978000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 18075000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Payable: 236301000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -653290000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -362808000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 202360000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Common Stock: 364371000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5939592000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 384661000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 3736787000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Current Assets: 4571289000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Current Debt: 29744000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 29744000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 1628461000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 150261000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Depreciation: 123211000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 123424000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 123424000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 123424000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 72874124.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Diluted EPS: 11.43
ACUTAAS.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 832897000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 3000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — EBIT: 1145841000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — EBITDA: 1269265000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 0.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — End Cash Position: 305326000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -122500000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 283267000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -308729000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -21326000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 7466000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 58073000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Goodwill: 203229000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 414581000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2303009000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2989330000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Gross Profit: 2393786000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Interest Expense: 24123000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 24123000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Interest Income: 21789000.00
ACUTAAS.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 21789000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -24123000.00
ACUTAAS.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 21789000.00
ACUTAAS.NS balance_sheet (annual, 2023-03-31) — Inventory: 1191730000.00